Suppr超能文献

IRAK-1 的最小结构诱导 TRAF6 降解。

Minimal structure of IRAK-1 to induce degradation of TRAF6.

机构信息

Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.

Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.

出版信息

Immunobiology. 2022 Sep;227(5):152256. doi: 10.1016/j.imbio.2022.152256. Epub 2022 Jul 30.

Abstract

Excessive activation of Toll-like receptor (TLR) leads to sepsis. Inflammatory responses to various microbiological components are initiated via different TLR proteins, but all TLR signals are transmitted by TRAF6. We reported that TRAF6 associated with ubiquitinated IRAK-1 undergoes proteasome-mediated degradation, suggesting that IRAK-1 has a negative regulatory role in TLR signaling. Here, we investigated the minimal structural region of IRAK-1 needed for degradation of TRAF6. The IRAK-1 protein contains an N-terminal death domain (DD; amino acids 1-102), a serine/proline/threonine-rich ProST domain (amino acids 103-197), a central kinase domain with an activation loop (amino acids 198-522), and the C-terminal C1 and C2 domains (amino acids 523-712), which contain two and one putative TRAF6-binding (TB) sites, respectively. TRAF6 degradation was severely impaired by deletion of the DD or C1 domain, and a mutant (DC1) containing only the DD and C1 domains could induce TRAF6 degradation. IRAK-1 mutants lacking the N- or C-terminal amino acids of DD induced little degradation. Deletion or mutation of TB2 (amino acids 585-591) in the C1 domain also inhibited TRAF6 degradation. An IRAK-1 mutant possessing only DD and TB2 did not induce TRAF6 degradation, although a mutant in which a short spacer was inserted between DD and TB2 induced TRAF6 degradation, which and DC1-induced degradation were inhibited by proteasome inhibitors. All IRAK-1 mutants that induced TRAF6 degradation could be immunoprecipitated with TRAF6. Meanwhile, NF-κB activation was observed for all IRAK-1 mutants-including those that failed to induce degradation and was severely impaired only for a mutant carrying mutations in both TBs of C1. These results demonstrate that only DD and TB2 separated by an appropriate distance can induce TRAF6 degradation. Conformational analysis of this minimal structural unit may aid development of low molecular compounds that negatively regulate TLR signaling.

摘要

Toll 样受体(TLR)过度激活可导致败血症。不同的 TLR 蛋白可引发对各种微生物成分的炎症反应,但所有 TLR 信号均由 TRAF6 转导。我们曾报道 TRAF6 与泛素化的 IRAK-1 结合后,通过蛋白酶体介导发生降解,这提示 IRAK-1 在 TLR 信号转导中具有负调控作用。在此,我们研究了 IRAK-1 中用于降解 TRAF6 的最小结构域。IRAK-1 蛋白包含一个 N 端死亡结构域(DD;氨基酸 1-102)、一个富含丝氨酸/脯氨酸/苏氨酸的 ProST 结构域(氨基酸 103-197)、一个带有激活环的中央激酶结构域(氨基酸 198-522)和一个 C 端 C1 和 C2 结构域(氨基酸 523-712),后者分别包含两个和一个假定的 TRAF6 结合(TB)位点。DD 或 C1 结构域缺失严重损害 TRAF6 的降解,仅包含 DD 和 C1 结构域的突变体(DC1)可诱导 TRAF6 降解。缺乏 DD 的 N 端或 C 端氨基酸的 IRAK-1 突变体几乎不能诱导降解。C1 结构域中 TB2(氨基酸 585-591)缺失或突变也抑制 TRAF6 降解。仅含有 DD 和 TB2 的 IRAK-1 突变体不能诱导 TRAF6 降解,尽管在 DD 和 TB2 之间插入短间隔子时可诱导 TRAF6 降解,而 DC1 诱导的降解和插入间隔子时的降解均被蛋白酶体抑制剂抑制。所有可与 TRAF6 免疫沉淀的 IRAK-1 突变体均可诱导 TRAF6 降解。同时,所有 IRAK-1 突变体均可观察到 NF-κB 激活,包括那些不能诱导降解的突变体,而在 C1 中两个 TB 均发生突变的突变体中 NF-κB 激活严重受损。这些结果表明,只有 DD 和 TB2 之间存在适当的距离才能诱导 TRAF6 降解。对该最小结构单元的构象分析可能有助于开发负调控 TLR 信号的低分子化合物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验